Differential diagnosis: distinguishing between ghostwriting and professional medical writing in biomedical journals.
Differential diagnosis: distinguishing between ghostwriting and professional medical writing in biomedical journals.
复制标题
鉴别诊断:区分生物医学期刊中的代笔和专业医学写作。
DOI:
10.1001/jamainternmed.2013.10420
复制
发表时间:
2013
影响因子:
39
通讯作者:
Cindy W. Hamilton
中科院分区:
文献类型:
--
作者:
Cindy W. Hamilton
But these products are not dietary supplements, contrary to assertions in the recently published Research Letter authored by Harel et al.1 The authors correctly identify many of the ingredients that are allowed to be present in dietary supplements, including vitamins, minerals, herbs, and amino acids. But pharmaceutical ingredients—such as sibutramine or sildenafil—may not be used in supplements, and products that contain these fail to meet the federal definition of dietary supplements. Nor are such products properly classified as drugs, since they are not approved drug products. Irrespective of how these illegal goods should be identified, however, it is certain that they are unlawful whenever and wherever they are sold. It is also certain that these illegal products present significant health risks to consumers, a concern that is shared by the article’s authors and the US supplement industry. That is why our organization and others have worked closely with the Food and Drug Administration (FDA) to call attention to this ongoing problem and to express strong support for active enforcement by the FDA. The authors suggest that the Dietary Supplement Health and Education Act2 (DSHEA) “has permitted the introduction of numerous supplement products, often containing active pharmaceutical ingredient, into the marketplace.”1(p927) This is not true. Rather, these products are marketed by those who ignore the laws of the United States3 and of every other country in which these dangerous goods are available.